Agranulocytosis Associated with Waldenström Macroglobulinemia

Acta Haematol. 2018;140(1):42-45. doi: 10.1159/000489482. Epub 2018 Aug 16.

Abstract

Currently, there are only 2 case reports of Waldenström macroglobulinemia (WM) associated with severe neutropenia. This is a case report of a woman with a past medical history of WM who presented with neutropenic fever. The patient's febrile neutropenia resolved after RCD chemotherapy (cyclophosphamide 750 mg/m2, dexamethasone 20 mg, and rituximab 375 mg/m2). Fourteen days after administration, the neutrophil level had started to rise and normalized after 6 days. To the best of our knowledge, this is the 3rd reported case of agranulocytosis due to WM.

Keywords: Agranulocytosis; Neutropenic fever; Waldenström.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Agranulocytosis / diagnosis*
  • Agranulocytosis / etiology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Dexamethasone / administration & dosage
  • Female
  • Humans
  • Leukocyte Count
  • Neutrophils / cytology
  • Positron Emission Tomography Computed Tomography
  • Rituximab / administration & dosage
  • Waldenstrom Macroglobulinemia / complications
  • Waldenstrom Macroglobulinemia / diagnosis*
  • Waldenstrom Macroglobulinemia / drug therapy

Substances

  • Rituximab
  • Dexamethasone
  • Cyclophosphamide